Lu Su Selected Research

Lu Su Research Topics

8	Neoplasms (Cancer) 01/2021 - 09/2015
3	Breast Neoplasms (Breast Cancer) 10/2020 - 01/2018
2	Infarction (Infarctions) 02/2020 - 01/2016
1	Urinary Tract Infections (Urinary Tract Infection) 01/2021
1	Endotoxemia 10/2020
1	Reperfusion Injury 02/2020
1	Ischemia 02/2020
1	Brain Ischemia (Cerebral Ischemia) 02/2020
1	Glioma (Gliomas) 08/2018
1	Dysbiosis 01/2018
1	Carcinogenesis 01/2018
1	Osteosarcoma (Osteogenic Sarcoma) 01/2018
1	Obesity 10/2017
1	Fatty Liver 10/2017
1	Insulin Resistance 10/2017
1	Metabolic Diseases (Metabolic Disease) 10/2017
1	Inflammation (Inflammations) 01/2015

3	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 08/2018 - 10/2017
2	Polysaccharides (Glycans)IBA 01/2019 - 01/2018
2	16S Ribosomal RNAIBA 01/2018 - 01/2018
1	PolymersIBA 01/2021
1	SugarsIBA 01/2021
1	MitogensIBA 01/2021
1	CateninsIBA 10/2020
1	Cadherins (E-Cadherin)IBA 10/2020
1	Tight Junction ProteinsIBA 10/2020
1	OccludinIBA 10/2020
1	Histones (Histone)IBA 02/2020
1	Tissue Kallikreins (Tissue Kallikrein)IBA 02/2020
1	salicylhydroxamic acid (SHAM)IBA 02/2020
1	triphenyltetrazoliumIBA 02/2020
1	Histone Deacetylase InhibitorsIBA 02/2020
1	Protein MethyltransferasesIBA 08/2018
1	AmidesIBA 08/2018
1	Protons (Proton)IBA 08/2018
1	APTIBA 08/2018
1	MethyltransferasesIBA 08/2018
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 07/2018
1	Glutathione (Reduced Glutathione)IBA 01/2018
1	Reducing AgentsIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2018
1	Dithiothreitol (Cleland's Reagent)IBA 01/2018
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2018
1	Lactate Dehydrogenase 5IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	LipidsIBA 10/2017
1	AdiponectinIBA 01/2015